European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.58% to 1,962.65 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and software firm, SAP (SAP), which rose 4.6% and 3% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which were up 2.9% and 2.1% respectively.
The decliners from continental Europe were led by pharmaceutical companies Novo Nordisk (NVO) and Sanofi (SNY), which lost 2.8% and 1.3% respectively. They were followed by biotech firm BioNTech (BNTX) and consumer goods company Unilever (UL), which dropped 1.2% and 1.1% respectively.
The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which advanced 5.1% and 4.1% respectively. They were followed by biotech company Autolus Therapeutics (AUTL) and educational publisher Pearson (PSO), which increased 1.1% and 0.9% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which fell 6.9% and 3% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and pharmaceutical company GSK (GSK), which were down 2.6% and 1.9% respectively.